Tumor necrosis factor production by human granulocytes

Y. Mandi, V. Endresz, L. Krenacs, K. Regely, M. Degre, I. Beladi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Human polymorphonuclear leukocytes kill WEHI 164 cells in an 18-hour 51Cr release assay. Antibody to human tumor necrosis factor (TNF) blocks the lysis of targets mediated by human granulocytes. Resting granulocytes produce an undetectable amount of TNF, if any. Granulocytes stimulated with Staphylococcus aureus release 250-500 U/ml TNFα. The specificity of the released TNF in the WEHI 164 cytotoxicity assay was confirmed by using neutralizing anti-TNFα monoclonal antibodies. The thymidine uptake of endothelial cells was inhibited by granulocyte-derived TNF. The identity of TNFα was further confirmed by molecular weight determination, by gel filtration on Sephacryl S-200, with a result of approximately 44,000. Besides their antimicrobial capacity, therefore, granulocytes may contribute to tumor rejection, inflammation and septic infections by releasing TNF.

Original languageEnglish
Pages (from-to)102-106
Number of pages5
JournalInternational Archives of Allergy and Applied Immunology
Volume96
Issue number2
Publication statusPublished - Dec 1 1991

    Fingerprint

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this